In accordance, treatment with anti-CD14 (IC14) during human endotoxemia strongly inhibited LPS-induced proinflammatory cytokine release, whereas the release of anti-inflammatory cytokines such as soluble TNF receptor type I and IL-1Ra was only delayed [64, 65]. This evidence concerns the gene CD14 and serum lipopolysaccharide activity.